Contracts Finder · Award
Oncotype DX Breast Cancer Testing
A public procurement published by East Sussex Healthcare NHS Trust via Contracts Finder.
- £272.7k
- Award value
- £272.7k
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Award
- Stage
Overview
Oncotype DX is a validated genomic assay recommended by NICE (DG34) for guiding chemotherapy decisions in specific cohorts of early breast cancer. It provides a Recurrence Score that stratifies patients into groups where chemotherapy is beneficial versus where endocrine therapy alone is sufficient. Additional information: This is a call off contract from framework 2023/S 000-028831 based on previous contracts usage.
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 85111800 — Pathology services
- Currency
- GBP
- Total award value
- £272,700
- Tender value
- £272,700
- First published
- 3 Mar 2026
- Last updated
- 3 Mar 2026
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Exact Sciences UK, Ltd. | 07484560 | 2 Mar 2026 | active | £272.7k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from East Sussex Healthcare NHS Trust
FAQs about this procurement
Who is the buyer for "Oncotype DX Breast Cancer Testing"?
Oncotype DX Breast Cancer Testing is a UK public-sector procurement published by East Sussex Healthcare NHS Trust via Contracts Finder.
Has "Oncotype DX Breast Cancer Testing" been awarded?
Yes — 1 award is recorded, with a reported total value of £272,700. The current lifecycle stage is "Award".
Which suppliers are involved in "Oncotype DX Breast Cancer Testing"?
1 supplier is linked: Exact Sciences UK, Ltd..
What is "Oncotype DX Breast Cancer Testing" worth?
The reported award value is £272,700.
When was "Oncotype DX Breast Cancer Testing" published?
It was first published on 3 Mar 2026 and last updated on 3 Mar 2026, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable